Pantipa SubhasitanontChantragan SrisomsapPhaibul PunyaritJisnuson SvastiChulabhorn Research InstitutePhramongkutklao College of MedicineMahidol University2018-08-202018-08-202006-01-01Cancer Genomics and Proteomics. Vol.3, No.6 (2006), 389-39417906245110965352-s2.0-33845992203https://repository.li.mahidol.ac.th/handle/123456789/23110Galectin-3 expression in thyroid diseases was studied by 1-DE immunoblotting. Expression was markedly elevated in thyroid papillary carcinoma, compared to follicular adenoma, follicular carcinoma or non-neoplastic diseases. Galectin-3 expression was also elevated in malignant cancers of bone, breast, colon, esophagus, larynx, lung and ovary. Four cases of thyroid papillary carcinoma with metastasis gave 2-3 bands on 1-DE immunoblotting. 2-DE immunoblotting of gelectin-3 showed 3 dark spots with MW/pI 32.9/8.29, 31.0/8.40 and 30.0/8.40 and 2 light spots.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyArticleSCOPUS